The disease detection technology developer has received cash from a consortium that included GV.

GV, the corporate venturing subsidiary of conglomerate Alphabet, yesterday backed a $65m series A round for US-based health technology producer Freenome.

The round was led by VC firm Andreessen Horowitz, with further participation from Data Collective, Founders Fund, Polaris Partners, Innovation Endeavors, Asset Management Ventures, Charles River Ventures and Spectrum 28.

Founded in 2014, Freenome is using machine learning, computer science and biology to develop simple and effective disease screenings, with an initial focus on lung, colorectal, breast and protaste…